Friday, March 1, 2013 Thursday, February 28, 2013- Do These Pipeline Drugs Hold the Key to AbbVie's Future?at Motley Fool (Thu, Feb 28)
- 101 Reasons to Stay Away From Drugs for This Diseaseat Motley Fool (Thu, Feb 28)
- PFIZER INC Files SEC form 10-K, Annual ReportEDGAR Online (Thu, Feb 28)
- Mylan’s CEO Says Strides Deal Helps Biotechnology Pushat Bloomberg (Thu, Feb 28)
- Priority Review for Bayer's DrugZacks (Thu, Feb 28)
- Mylan rises on purchase of injectable drug makerAP (Thu, Feb 28)
- Why Is the Blockbuster Model Breaking?at Motley Fool (Thu, Feb 28)
- The Zacks Analyst Blog Highlights: Bayer, Novartis, Pfizer, Eli Lilly and MicrosoftZacks (Thu, Feb 28)
- You Have to Love a Lucrative 'Drug Deal'TheStreet (Thu, Feb 28)
- You Have to Love a Lucrative 'Drug Deal'at TheStreet (Thu, Feb 28)
- UPDATE 2-Bayer shares at record after upbeat drug sales viewat Reuters (Thu, Feb 28)
Wednesday, February 27, 2013Add PFE News to My Yahoo!  | |
|